Tasi Nelson is an experienced professional in the field of clinical development, currently serving as the Therapeutic Area Head for Early Clinical Development at Genentech since June 2008, with a focus on areas such as Cardiovascular/Metabolism, Immunology, Infectious Disease, Neuroscience, Ophthalmology, and Respiratory. Previously held roles at Genentech include Clinical Program Director and Sr. Clinical Program Leader, specializing in Immunology and Respiratory Diseases, as well as Infectious Disease and Cardiovascular/Metabolism. Prior experience includes senior positions at Covance, Roche Pharmaceuticals, and Quintiles, with a foundation in clinical research and project management. Tasi Nelson holds an MS in Health Science, Clinical Research Administration from The George Washington University School of Medicine and Health Sciences and a B.S. in Biology from Virginia Tech.
This person is not in any teams
This person is not in any offices